Tsuruya K - Search Results

1

Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism.

Tokumoto M, Tsuruya K, Fukuda K, Kanai H, Kuroki S, Hirakata H. Tokumoto M, et al. Among authors: tsuruya k. Kidney Int. 2002 Oct;62(4):1196-207. doi: 10.1111/j.1523-1755.2002.kid585.x. Kidney Int. 2002. PMID: 12234290 Free article.

2

Successful use of single-lumen, urokinase immobilized femoral catheters as a temporary access for haemodialysis.

Takeda K, Harada A, Kubo M, Inenaga T, Tsuruya K, Mitsuiki K, Hirakata H, Fujishima M. Takeda K, et al. Among authors: tsuruya k. Nephrol Dial Transplant. 1998 Jan;13(1):130-3. doi: 10.1093/ndt/13.1.130. Nephrol Dial Transplant. 1998. PMID: 9481728

3

Combination therapy using prednisolone and cyclophosphamide slows the progression of moderately advanced IgA nephropathy.

Tsuruya K, Harada A, Hirakata H, Mitsuiki K, Johko T, Kondoh H, Takechi S, Fujishima M. Tsuruya K, et al. Clin Nephrol. 2000 Jan;53(1):1-9. Clin Nephrol. 2000. PMID: 10661476

4

A novel superoxide-producing NAD(P)H oxidase in kidney.

Shiose A, Kuroda J, Tsuruya K, Hirai M, Hirakata H, Naito S, Hattori M, Sakaki Y, Sumimoto H. Shiose A, et al. Among authors: tsuruya k. J Biol Chem. 2001 Jan 12;276(2):1417-23. doi: 10.1074/jbc.M007597200. J Biol Chem. 2001. PMID: 11032835 Free article.

5

Optimal hematocrit for the maximum oxygen delivery to the brain with recombinant human erythropoietin in hemodialysis patients.

Hirakata H, Kanai H, Fukuda K, Tsuruya K, Ishida I, Kubo M, Hirano T, Hirakata E, Kuwabara Y, Fujishima M. Hirakata H, et al. Among authors: tsuruya k. Clin Nephrol. 2000 May;53(5):354-61. Clin Nephrol. 2000. PMID: 11305808

6

Ilioinguinal neuralgia complicating percutaneous renal biopsy.

Kanai H, Hirakawa M, Arimura Y, Taniguchi M, Tsuruya K, Masutani K, Ninomiya T, Sugawara K, Koga Y, Hirakata H. Kanai H, et al. Among authors: tsuruya k. J Neurol. 2001 Aug;248(8):708-9. doi: 10.1007/s004150170120. J Neurol. 2001. PMID: 11569903 No abstract available.

7

Predominance of Th1 immune response in diffuse proliferative lupus nephritis.

Masutani K, Akahoshi M, Tsuruya K, Tokumoto M, Ninomiya T, Kohsaka T, Fukuda K, Kanai H, Nakashima H, Otsuka T, Hirakata H. Masutani K, et al. Among authors: tsuruya k. Arthritis Rheum. 2001 Sep;44(9):2097-106. doi: 10.1002/1529-0131(200109)44:9<2097::AID-ART360>3.0.CO;2-6. Arthritis Rheum. 2001. PMID: 11592372 Free article.

8

Protection by a radical scavenger edaravone against cisplatin-induced nephrotoxicity in rats.

Sueishi K, Mishima K, Makino K, Itoh Y, Tsuruya K, Hirakata H, Oishi R. Sueishi K, et al. Among authors: tsuruya k. Eur J Pharmacol. 2002 Sep 13;451(2):203-8. doi: 10.1016/s0014-2999(02)02251-3. Eur J Pharmacol. 2002. PMID: 12231392

9

Diffuse proliferative glomerulonephritis after bone marrow transplantation.

Suehiro T, Masutani K, Yokoyama M, Tokumoto M, Tsuruya K, Fukuda K, Kanai H, Katafuchi R, Nagatoshi Y, Hirakata H. Suehiro T, et al. Among authors: tsuruya k. Clin Nephrol. 2002 Sep;58(3):231-7. doi: 10.5414/cnp58231. Clin Nephrol. 2002. PMID: 12356194 Review.

10

Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death.

Tsuruya K, Ninomiya T, Tokumoto M, Hirakawa M, Masutani K, Taniguchi M, Fukuda K, Kanai H, Kishihara K, Hirakata H, Iida M. Tsuruya K, et al. Kidney Int. 2003 Jan;63(1):72-82. doi: 10.1046/j.1523-1755.2003.00709.x. Kidney Int. 2003. PMID: 12472770 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

498 results

Search Page